Mongolia has vast mineral resources and boasts a high rate of economic expansion, ranking top in the world for growth in 2011. This trend is expected to continue, with real GDP forecast to rise by an average annual rate of 22% between 2007 and 2015.
On the healthcare front, the Mongolian government has announced its Health Sector Master Plan, which calls for aggressive investment in healthcare infrastructure. Consequently, growth in this market is likely to accelerate. Despite the existence of a host of companies that cite low prices as their strength, the country’s Ministry of Health is focusing instead on improving quality, and requires pharmaceutical registrations by manufacturers who provide reagents. This move is intended to encourage manufacturers to provide higher-quality products, thereby raising the overall quality of healthcare in the country.
Sysmex has conducted sales and support activities in Mongolia via a local distributor since 2007. In 2008, the Company signed a support agreement for External Quality Assessment (EQA) with Mongolia’s Ministry of Health to help standardize the testing results of medical facilities within the country. Since that time, we have conducted activities aimed at building the Sysmex brand, such as by installing hematology standard analyzers in national hospitals1. Sysmex has a leading share of the market in its mainstay hematology field, and is well regarded by a wide range of customers, from small and medium-sized facilities to large-scale institutions.
Along with the establishment of a representative office, Sysmex is contributing to the standardization of clinical chemistry testing in the country. Through its representative office, Sysmex will work with local distributors on sales, and scientific and support service initiatives; as well as reinforcing its lineup of products in hematology and non-hematology fields2.
Going forward, Sysmex will continue contributing to the development of healthcare by stepping up its establishment of sales and support networks in Asian and other emerging markets.